These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 14648447)

  • 1. Vulnerable among the vulnerable: drug users in situations of poverty and indigence in Argentina.
    Vivas LE; Radulich G; Bruno D
    Clin Infect Dis; 2003 Dec; 37 Suppl 5():S358-61. PubMed ID: 14648447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug use, harm reduction, and health policies in Argentina: obstacles and new perspectives.
    Inchaurraga S
    Clin Infect Dis; 2003 Dec; 37 Suppl 5():S366-71. PubMed ID: 14648449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obstacles to the development of prevention and public health policies in Argentina.
    Touzé G
    Clin Infect Dis; 2003 Dec; 37 Suppl 5():S372-5. PubMed ID: 14648450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Harm reduction actions as a health care construction process at a public health center in Rosario, Argentina.
    Lavarello D; Lottero M; Chavero M; Toledo A; Espínola M; Gerlero S; Liborio M
    Clin Infect Dis; 2003 Dec; 37 Suppl 5():S353-7. PubMed ID: 14648446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The challenge of implementation of preventive programs in a developing country: experiences, situations, and perspectives in Uruguay.
    Osimani ML
    Clin Infect Dis; 2003 Dec; 37 Suppl 5():S422-6. PubMed ID: 14648458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 'Social evils' and harm reduction: the evolving policy environment for human immunodeficiency virus prevention among injection drug users in China and Vietnam.
    Hammett TM; Wu Z; Duc TT; Stephens D; Sullivan S; Liu W; Chen Y; Ngu D; Des Jarlais DC
    Addiction; 2008 Jan; 103(1):137-45. PubMed ID: 18028519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human immunodeficiency virus/acquired immunodeficiency syndrome prevention in injection drug users and their partners and children: lessons learned in Latin America--the Argentinean case.
    Rossi D; Goltzman P; Cymerman P; Touzé G; Weissenbacher M
    Clin Infect Dis; 2003 Dec; 37 Suppl 5():S362-5. PubMed ID: 14648448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Principles of harm reduction. Harm Reduction Coalition.
    Newsline People AIDS Coalit N Y; 1998 Jun; ():7-8. PubMed ID: 11367472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lessons from the history of the human immunodeficiency virus/acquired immunodeficiency syndrome epidemic among Spanish drug injectors.
    De La Fuente L; Bravo MJ; Barrio G; Parras F; Suárez M; Rodés A; Noguer I
    Clin Infect Dis; 2003 Dec; 37 Suppl 5():S410-5. PubMed ID: 14648456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Harm reduction policies in Argentina: a critical view.
    Epele ME; Pecheny M
    Glob Public Health; 2007; 2(4):342-58. PubMed ID: 19283632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in human immunodeficiency virus infection among drug users in a detoxification unit.
    Muga R; Sanvisens A; Egea JM; Tor J; Rey-Joly C
    Clin Infect Dis; 2003 Dec; 37 Suppl 5():S404-9. PubMed ID: 14648455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of a harm-reduction programme on soft tissue infections among injecting drug users of Kolkata, India.
    Bhattacharya MK; Naik TN; Palit A; Bhattacharya SK
    J Health Popul Nutr; 2006 Mar; 24(1):121-2. PubMed ID: 16796159
    [No Abstract]   [Full Text] [Related]  

  • 13. Measuring effectiveness of needle and syringe exchange programmes for prevention of HIV among injecting drug users.
    Amundsen EJ
    Addiction; 2006 Jul; 101(7):911-2. PubMed ID: 16771880
    [No Abstract]   [Full Text] [Related]  

  • 14. A pilot study of the NGO-based relational intervention model for HIV prevention among drug users in China.
    Chen HT; Liao Q
    AIDS Educ Prev; 2005 Dec; 17(6):503-14. PubMed ID: 16398573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determinants of injection drug user (IDU) syringe sharing: the relationship between availability of syringes and risk network member characteristics in Winnipeg, Canada.
    Shaw SY; Shah L; Jolly AM; Wylie JL
    Addiction; 2007 Oct; 102(10):1626-35. PubMed ID: 17854339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prevalence of human immunodeficiency virus (HIV)-Trypanosoma cruzi co-infection and injectable-drugs abuse in a Buenos Aires health center].
    Dolcini G; Ambrosioni J; Andreani G; Pando MA; Martínez Peralta L; Benetucci J
    Rev Argent Microbiol; 2008; 40(3):164-6. PubMed ID: 19024504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Economic perspectives on injecting drug use.
    Bloom DE; Mahal A; O'Flaherty B
    Adv Health Econ Health Serv Res; 2005; 16():371-95. PubMed ID: 17867249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Baseline findings from the third collaborative injection drug users study/drug users intervention trial (CIDUS III/DUIT).
    Booth RE; Strathdee SA
    Drug Alcohol Depend; 2007 Nov; 91 Suppl 1():S1-3. PubMed ID: 17889451
    [No Abstract]   [Full Text] [Related]  

  • 19. Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: a comprehensive approach.
    Birkhead GS; Klein SJ; Candelas AR; O'Connell DA; Rothman JR; Feldman IS; Tsui DS; Cotroneo RA; Flanigan CA
    Int J Drug Policy; 2007 Oct; 18(5):417-25. PubMed ID: 17854731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Social context of needle selling in Baltimore, Maryland.
    Latkin CA; Davey MA; Hua W
    Subst Use Misuse; 2006; 41(6-7):901-13. PubMed ID: 16809178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.